港股公告掘金 | 小鹏汽车-W2024年全年总交付量达到19万辆，同比增长34%

智通财经2025-01-02

重大事项：信达生物(01801)与罗氏达成新一代DLL3 抗体偶联药物的全球独家许可协议百心安-B(02185)：嘉兴国健百心股权投资合伙企业向浙江百心安注资约1.556亿元和黄医药(00013)宣布沃瑞沙®和泰瑞沙®联合疗法用于治疗肺癌患者的中国新药上市申请获受理并获纳入优先审评兆科眼科-B(06622)用于治疗wAMD的TAB014的第III期临床试验达到主要终点及关键次要终点。君圣泰医药-B...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2500920282?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-01-02 23:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2500920282","market":"hk","top_or_hot":-1,"title":"港股公告掘金 | 小鹏汽车-W2024年全年总交付量达到19万辆，同比增长34%","media":"智通财经","content":"<div>\n<p>重大事项：信达生物(01801)与罗氏达成新一代DLL3 抗体偶联药物的全球独家许可协议百心安-B(02185)：嘉兴国健百心股权投资合伙企业向浙江百心安注资约1.556亿元和黄医药(00013)宣布沃瑞沙®和泰瑞沙®联合疗法用于治疗肺癌患者的中国新药上市申请获受理并获纳入优先审评兆科眼科-B(06622)用于治疗wAMD的TAB014的第III期临床试验达到主要终点及关键次要终点。君圣泰医药-B...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1232852.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股公告掘金 | 小鹏汽车-W2024年全年总交付量达到19万辆，同比增长34%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股公告掘金 | 小鹏汽车-W2024年全年总交付量达到19万辆，同比增长34%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-02 23:09 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1232852.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>重大事项：信达生物(01801)与罗氏达成新一代DLL3 抗体偶联药物的全球独家许可协议百心安-B(02185)：嘉兴国健百心股权投资合伙企业向浙江百心安注资约1.556亿元和黄医药(00013)宣布沃瑞沙®和泰瑞沙®联合疗法用于治疗肺癌患者的中国新药上市申请获受理并获纳入优先审评兆科眼科-B(06622)用于治疗wAMD的TAB014的第III期临床试验达到主要终点及关键次要终点。君圣泰医药-B...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1232852.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XPEV","symbol_name":"小鹏集团","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1232852.html","article_id":"2500920282","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2500920282","pubTimestamp":1735830598,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"重大事项：信达生物与罗氏达成新一代DLL3 抗体偶联药物的全球独家许可协议百心安-B：嘉兴国健百心股权投资合伙企业向浙江百心安注资约1.556亿元和黄医药宣布沃瑞沙和泰瑞沙联合疗法用于治疗肺癌患者的中国新药上市申请获受理并获纳入优先审评兆科眼科-B用于治疗wAMD的TAB014的第III期临床试验达到主要终点及关键次要终点。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"XPEV":"小鹏集团","BK1588":"回港中概股","BK4099":"汽车制造商","BK4526":"热门中概股","EVS.SI":"MSCI China Electric Vehicles and Future Mobility ETF-NikkoAM","BK4555":"新能源车","09868":"小鹏集团-W","BK4505":"高瓴资本持仓","HSTECH":"恒生科技指数","BK1539":"汽车股","BK1119":"汽车制造商","BK1587":"次新股","HSCEI":"国企指数","YANG":"三倍做空富时中国ETF-Direxion","BK4551":"寇图资本持仓","07226":"南方两倍做多恒科","LU0593848301.USD":"未来资产亚洲卓越消费股票基金A","BK1575":"同股不同权","BK1610":"ETF&股票定投概念"},"translate_title":"Hong Kong stock announcement Nuggets XPeng Motors-The total delivery volume of W in 2024 will reach 190,000 vehicles, a year-on-year increase of 34%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XPEV":1,"YANG":1,"07226":1,"HSTECH":1,"HSCEI":1,"09868":1,"EVS.SI":0.6},"content_text":"重大事项：信达生物(01801)与罗氏达成新一代DLL3 抗体偶联药物的全球独家许可协议百心安-B(02185)：嘉兴国健百心股权投资合伙企业向浙江百心安注资约1.556亿元和黄医药(00013)宣布沃瑞沙®和泰瑞沙®联合疗法用于治疗肺癌患者的中国新药上市申请获受理并获纳入优先审评兆科眼科-B(06622)用于治疗wAMD的TAB014的第III期临床试验达到主要终点及关键次要终点。君圣泰医药-B(02511)完成HTD1801头对头达格列净治疗2型糖尿病III期临床试验患者入组石四药集团(02005)取得醋酸钠林格葡萄糖注射液(500ml)的药品生产注册批件瑞科生物-B(02179)新佐剂重组带状疱疹疫苗REC610 完成III期临床研究入组海普瑞(09989)与永太药业签订加巴喷丁胶囊 Gabapentin分销协议石药集团(01093)：SYS 6010于中国获突破性治疗认定复星医药(02196)：注射用雷替曲塞药品注册申请获国家药监局受理远大医药(00512)：全球创新温度敏感性栓塞剂在中国的注册性临床研究完成首例患者入组兆科眼科-B(06622)：国家药监局受理用于治疗儿童近视加深的NVK002的简化新药申请迈博药业-B(02181)：巴基斯坦药品监管局批准核心产品CMAB008(注射用英夫利西单抗)的注册国富创新(00290)与量旋科技签订战略合作协议经营业绩：小鹏汽车-W(09868)2024年全年总交付量达到19万辆，同比增长34%秦港股份(03369)：2024年度吞吐量总计4.14亿吨，同比增长5.66%越秀交通基建(01052)：广州北二环高速10月路费收入为8189.2万元 同比减少7.7%","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2500920282","isCrawlerRequest":true}